Search Results - "Christensen, Robbin"

Phase I Pharmacokinetic and Pharmacodynamic Study of the Multikinase Inhibitor Sorafenib in Combination With Clofarabine and Cytarabine in Pediatric Relapsed/Refractory Leukemia by INABA, Hiroto, RUBNITZ, Jeffrey E, POUNDS, Stanley B, PUI, Ching-Hon, RIBEIRO, Raul C, CAMPANA, Dario, BAKER, Sharyn D, COUSTAN-SMITH, Elaine, LIE LI, FURMANSKI, Brian D, MASCARA, Gerard P, HEYM, Kenneth M, CHRISTENSEN, Robbin, ONCIU, Mihaela, SHURTLEFF, Sheila A

“…To assess the toxicity, pharmacokinetics, and pharmacodynamics of multikinase inhibitor sorafenib in combination with clofarabine and cytarabine in children…”
Get full text

Long-Term Efficacy of Methylphenidate in Enhancing Attention Regulation, Social Skills, and Academic Abilities of Childhood Cancer Survivors by CONKLIN, Heather M, REDDICK, Wilburn E, XIAOPING XIONG, KHAN, Raja B, ASHFORD, Jason, OGG, Susan, HOWARD, Scott C, MORRIS, E. Brannon, BROWN, Ronald, BONNER, Melanie, CHRISTENSEN, Robbin, SHENGJIE WU

“…Methylphenidate (MPH) ameliorates attention problems experienced by some cancer survivors in the short term, but its long-term efficacy is unproven. This study…”
Get full text

Octreotide Therapy of Pediatric Hypothalamic Obesity: A Double-Blind, Placebo-Controlled Trial by Lustig, Robert H., Hinds, Pamela S., Ringwald-Smith, Karen, Christensen, Robbin K., Kaste, Sue C., Schreiber, Randi E., Rai, Shesh N., Lensing, Shelly Y., Wu, Shengjie, Xiong, Xiaoping

“…Hypothalamic obesity is a devastating complication in children surviving brain tumors and/or cranial irradiation. These subjects are thought to exhibit…”
Get full text

Short-Term Efficacy of Methylphenidate: A Randomized, Double-Blind, Placebo-Controlled Trial Among Survivors of Childhood Cancer by MULHERN, Raymond K, KHAN, Raja B, REDDICK, Wilburn E, KAPLAN, Stuart, HELTON, Susan, CHRISTENSEN, Robbin, BONNER, Melanie, BROWN, Ronald, XIAOPING XIONG, SENGJIE WU, GURURANGAN, Sridharan

“…Children surviving acute lymphoblastic leukemia (ALL) and malignant brain tumors (BTs) have a higher incidence of attention and learning problems in school…”
Get full text

Alternative formulations of sorafenib for use in children by Navid, Fariba, Christensen, Robbin, Inaba, Hiroto, Li, Lie, Chen, Zhaoyuan, Cai, Xiangjun, Regel, Joshua, Baker, Sharyn D.

“…Background Sorafenib is an oral multikinase inhibitor with antiangiogenic and antitumor activity. In most cases, the commercially available 200 mg tablet is…”
Get full text

Immediate Neurocognitive Effects of Methylphenidate on Learning-Impaired Survivors of Childhood Cancer by THOMPSON, Stephen J, LEIGH, Laurie, HUDSON, Melissa M, MULHERN, Raymond K, CHRISTENSEN, Robbin, XIAOPING XIONG, KUN, Larry E, HEIDEMAN, Richard L, REDDICK, W. Eugene, GAJJAR, Amar, MERCHANT, Thomas, PUI, Ching-Hon

“…To test if methylphenidate (MPH) has an objective beneficial effect on immediate performance on tests of neurocognitive functions among learning-impaired…”
Get full text

Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trial by Gaur, Aditya H, McCarthy, James S, Panetta, John C, Dallas, Ronald H, Woodford, John, Tang, Li, Smith, Amber M, Stewart, Tracy B, Branum, Kristen C, Freeman, Burgess B, Patel, Nehali D, John, Elizabeth, Chalon, Stephan, Ost, Shelley, Heine, Ryan N, Richardson, Julie L, Christensen, Robbin, Flynn, Patricia M, Van Gessel, Yvonne, Mitasev, Branko, Möhrle, Jörg J, Gusovsky, Fabian, Bebrevska, Lidiya, Guy, R Kiplin

“…(+)-SJ000557733 (SJ733) is a novel, orally bioavailable inhibitor of Plasmodium falciparum ATP4. In this first-in-human and induced blood-stage malaria phase…”
Get full text

A randomized double‐blind placebo‐controlled trial of the effectiveness of melatonin on neurocognition and sleep in survivors of childhood cancer by Lubas, Margaret M., Mandrell, Belinda N., Greene, William L., Howell, Carrie R., Christensen, Robbin, Kimberg, Cara I., Li, Chenghong, Ness, Kirsten K., Srivastava, Deo Kumar, Hudson, Melissa M., Robison, Leslie L., Krull, Kevin R., Brinkman, Tara M.

“…Background Adult survivors of childhood cancer are at risk of developing sleep and neurocognitive problems, yet few efficacious interventions exist targeting…”
Get full text

Efficacy of Glucarpidase (Carboxypeptidase G2) in Patients with Acute Kidney Injury After High-Dose Methotrexate Therapy by Widemann, Brigitte C., Schwartz, Stefan, Jayaprakash, Nalini, Christensen, Robbin, Pui, Ching-Hon, Chauhan, Nikhil, Daugherty, Claire, King, Thomas R., Rush, Janet E., Howard, Scott C.

“…Study Objective Because the incidence rate of renal impairment is 2–10% for patients treated with high‐dose methotrexate and renal impairment develops in…”
Get full text

Smaller white‐matter volumes are associated with larger deficits in attention and learning among long‐term survivors of acute lymphoblastic leukemia by Reddick, Wilburn E., Shan, Zuyao Y., Glass, John O., Helton, Susan, Xiong, Xiaoping, Wu, Shengjie, Bonner, Melanie J., Howard, Scott C., Christensen, Robbin, Khan, Raja B., Pui, Ching‐Hon, Mulhern, Raymond K.

“…BACKGROUND The primary objective of this study was to test the hypothesis that survivors of childhood acute lymphoblastic leukemia (ALL) have deficits in…”
Get full text

Acute Neurocognitive Response to Methylphenidate Among Survivors of Childhood Cancer: A Randomized, Double-Blind, Cross-Over Trial by Conklin, Heather M., Khan, Raja B., Reddick, Wilburn E., Helton, Susan, Brown, Ronald, Howard, Scott C., Bonner, Melanie, Christensen, Robbin, Wu, Shengjie, Xiong, Xiaoping, Mulhern, Raymond K.

“…Objective To investigate the acute efficacy and adverse side effects of methylphenidate (MPH) among survivors of childhood cancer [acute lymphoblastic leukemia…”
Get full text

Addressing challenges of clinical trials in acute pain: The Pain Management of Vaso-occlusive Crisis in Children and Young Adults with Sickle Cell Disease Study by Nottage, Kerri A, Hankins, Jane S, Faughnan, Lane G, James, Dustin M, Richardson, Julie, Christensen, Robbin, Kang, Guolian, Smeltzer, Matthew, Cancio, Maria I, Wang, Winfred C, Anghelescu, Doralina L

“…Background/aims: Neuropathic pain is a known component of vaso-occlusive pain in sickle cell disease; however, drugs targeting neuropathic pain have not been…”
Get full text

Stability of Cyclophosphamide in Extemporaneous Oral Suspensions by Kennedy, Rachel, Groepper, Daniel, Tagen, Michael, Christensen, Robbin, Navid, Fariba, Gajjar, Amar, Stewart, Clinton F

“…Background: Cyclophosphamide, an alkylating agent, is widely used for the treatment of many adult and pediatric malignancies. The stability of cyclophosphamide…”
Get full text

Stability of Sunitinib in Oral Suspension by Navid, Fariba, Christensen, Robbin, Minkin, Patton, Stewart, Clinton F, Furman, Wayne L, Baker, Sharyn

“…Background: Sunitinib Is a novel, oral, multitargeted tyrosine kinase Inhibitor with antiangiogenic and antitumor activity. No liquid formulation of sunitinib…”
Get full text

Octreotide therapy of pediatric hypothalamic obesity: A double-blind, placebo-controlled trial : Endocrine care: Of special interest to the practice of endocrinology by LUSTIG, Robert H, HINDS, Pamela S, RINGWALD-SMITH, Karen, CHRISTENSEN, Robbin K, KASTE, Sue C, SCHREIBER, Randi E, RAI, Shesh N, LENSING, Shelly Y, SHENGJIE WU, XIAOPING XIONG

Get full text